Unliganded thyroid hormone receptor β1 inhibits proliferation of murine fibroblasts by delaying the onset of the G1 cell-cycle signals

Oncogene

Volumn 23, Issue 54, 2004, Pages 8756-8765

  Porlan, Eva ^a   Vega, Sonia ^a,b   Iglesias, Teresa ^a   Rodríguez Peña, Angeles ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Cell cycle; Cell proliferation; E2F transcription factor; Thyroid hormone; Thyroid hormone receptors; TR 1

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; DNA; HORMONE; ISOPROTEIN; LIGAND; PROTEIN P27; RETINOBLASTOMA PROTEIN; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR BETA1; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENT; FIBROBLAST; GENETIC TRANSFECTION; INHIBITION KINETICS; LIGAND BINDING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SERUM; SIGNAL TRANSDUCTION; STIMULATION; TIME;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIVISION; DNA PRIMERS; FIBROBLASTS; FLOW CYTOMETRY; G1 PHASE; IMMUNOPRECIPITATION; LIGANDS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWISS 3T3 CELLS; THYROID HORMONE RECEPTORS BETA;

ANIMALIA; MURINAE;

EID: 9944264074     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208126     Document Type: Article

References (40)

1. Barrera-Hernandez G, Zhan Q, Wong R and Cheng SY. (1998). DNA Cell Biol., 17, 743-750.
2. Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G and Beug H. (1998). EMBO J., 17, 4291-4303.
3. Baumann CT, Maruvada P, Hager GL and Yen PM. (2001). J. Biol. Chem., 276, 11237-11245.
4. Billon N, Tokumoto Y, Forrest D and Raff M. (2001). Dev. Biol., 235, 110-120.
5. Brown DD, Wang Z, Kanamori A, Eliceiri B, Furlow JD and Schwartzman R. (1995). Recent. Prog. Horm. Res., 50, 309-315.
6. Campanero MR, Armstrong MI and Flemington EK. (2000). Proc. Natl. Acad. Sci. USA, 97, 6481-6486.
7. Carre JL, Demerens C, Rodriguez-Pena A, Floch HH, Vincendon G and Sarlieve LL. (1998). J. Neurosci. Res., 54, 584-594.
8. Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P, Laudet V and Samarut J. (1997). Mol. Endocrinol., 11, 1278-1290.
9. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
10. Durand B and Raff M. (2000). BioEssays, 22, 64-71.
11. Durand B, Gao FB and Raff M. (1997). EMBO J., 16, 306-317.
12. Flamant F and Samarut J. (2003). Trends Endocrinol. Metab., 14, 85-90.
13. Forrest D, Sjoberg M and Vennstrom B. (1990). EMBO J., 9, 1519-1528.
14. Gonzalez-Sancho JM, Garcia V, Bonilla F and Munoz A. (2003). Cancer Lett., 192, 121-132.
15. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, Elmquist JK, Cohen RN and Wondisford FE. (2001). Proc. Natl. Acad. Sci. USA, 98, 3998-4003.
16. Hayashi Y, Sunthornthepvarakul T and Refetoff S. (1994). J. Clin. Invest., 94, 607-615.
17. Herwig S and Strauss M. (1997). Eur. J. Biochem., 246, 581-601; J. Biol. Chem., 275, 1787, 2000.
18. Herwig S and Strauss M. (1997). Eur. J. Biochem., 246, 581-601; J. Biol. Chem., 275, 1787, 2000.
19. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW and Moore DD. (1989). Nature, 337, 659-661.
20. Lebel JM, Dussault JH and Puymirat J. (1994). Proc. Natl. Acad. Sci. USA, 91, 2644-2648.
21. Markowitz S, Haut M, Stellate T, Gerbic C and Molkentin K. (1989). J. Clin. Invest., 84, 1683-1687.
22. Morgenstern JP and Land H. (1990). Nucleic Acids Res., 18, 3587-3596.
23. Nygard M, Wahlstrom GM, Gustafsson MV, Tokumoto YM and Bondesson M. (2003). Mol. Endocrinol., 17, 79-92.
24. Oberste-Berghaus C, Zanger K, Hashimoto K, Cohen RN, Hollenberg AN and Wondisford FE. (2000). J. Biol. Chem., 275, 1787-1792.
25. Oppenheimer JH and Schwartz HL. (1997). Endocr. Rev., 18, 462-475.
26. O'Shea PJ and Williams GR. (2002). J. Endocrinol., 175, 553-570.
27. Paavonen T. (1982). Scand J. Immunol., 15, 211-215.
28. Pastor R, Bernal J and Rodriguez-Pena A. (1994). Oncogene, 9, 1081-1089.
29. Perez-Juste G and Aranda A. (1999). J. Biol. Chem., 274, 5026-5031.
30. Qi JS, Desai-Yajnik V, Yuan Y and Samuels HH. (1997). Mol. Cell. Biol., 17, 7195-7207.
31. Rodriguez ER, Tan CD, Onwuta US, Yu ZX, Ferrans VJ and Parrillo JE. (1994). Biochem Biophys Res. Commun., 205, 652-658.
32. Rozengurt E and Sinnett-Smith J. (1983). Proc. Natl. Acad. Sci. USA, 80, 2936-2940.
33. Samuels HH. Stanley F and Casanova J. (1979). Endocrinology, 105, 80-85.
34. Sherr CJ, Kato J, Quelle DE, Matsuoka M and Roussel MF. (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 11-19.
35. Strait KA, Schwartz HL, Perez-Castillo A and Oppenheimer JH. (1990). J. Biol. Chem., 265, 10514-10521.
36. Suzuki H, Willingham MC and Cheng SY. (2002). Thyroid, 12, 963-969.
37. Tokumoto YM, Apperly JA, Gao FB and Raff MC. (2002). Dev. Biol., 245, 224-234.
38. Yap N, Yu CL and Cheng SY. (1996). Proc. Natl. Acad. Sci. USA, 93, 4273-4277.
39. Yen PM. (2003). Trends Endocrinol. Metab., 14, 327-333.
40. Yen PM, Wilcox EC, Hayashi Y, Refetoff S and Chin WW. (1995). Endocrinology, 136, 2845-2851.